Showing 641 - 660 results of 15,005 for search '(( significant ((changes decrease) OR (linear decrease)) ) OR ( significant increase decrease ))', query time: 0.63s Refine Results
  1. 641

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Aged micro­(nano)­plastics (MNPs) are normally the ultimate state of plastics in the environment after aging. The changes in the physical and chemical characteristics of aged MNPs significantly influence their environmental behavior by releasing additives, forming byproducts, and adsorbing contaminants. …”
  2. 642

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Aged micro­(nano)­plastics (MNPs) are normally the ultimate state of plastics in the environment after aging. The changes in the physical and chemical characteristics of aged MNPs significantly influence their environmental behavior by releasing additives, forming byproducts, and adsorbing contaminants. …”
  3. 643
  4. 644

    Flow chart of sediment P fractionation procedure. by Jiayu Hu (673291)

    Published 2025
    “…The NH<sub>4</sub>Cl-Po and NaHCO<sub>3</sub>-Po concentrations in sediments showed the greatest decrease (accounting for 97.6% of total decrease) during the experiment. …”
  5. 645
  6. 646
  7. 647

    Changes in foveal location after surgery. by Seung Min Lee (1644409)

    Published 2025
    “…</p><p>Conclusions</p><p>The macular topography significantly changed after iERM removal; the fovea moved nasally, and the distance between the superior and inferior vascular arcades increased. …”
  8. 648

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  9. 649

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  10. 650

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655
  16. 656
  17. 657
  18. 658
  19. 659
  20. 660

    Cohort characteristics. by Vincent Pey (21433304)

    Published 2025
    “…Concomitantly, the lactate/pyruvate ratio significantly increased (12.81 + /- 0.90 vs 67.1 + /- 7.94; p < 0.0001) while the acetoacetate/β-hydroxybutyrate ratio significantly decreased (1.11 + /- 0.19 vs. 0.54 + /- 0.05 at 0 min; p = 0.0055). …”